Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Français (Suisse)
Italiano
Nederlands (Nederland)
Nederlands (België)
MARKETS
Equities
United States
North America
Europe
Asia
Middle East
More Equities
Indexes
S&P 500
DOW JONES
NASDAQ 100
EURO STOXX 50
NIKKEI 225
More Indexes
Currency / Forex
USD / EUR
USD / CAD
USD / MXN
USD / BRL
USD / INR
More Currencies
Commodities
GOLD
CRUDE OIL (WTI)
CRUDE OIL (BRENT)
SILVER
PLATINUM
More Commodities
Cryptocurrencies
BITCOIN
ETHEREUM
Trackers & ETF
Rankings and News
Advanced Search
NEWS
Latest News
Companies
Markets
Economy
Currency / Forex
Commodities
Interest Rates
Finance Pro.
Business Leaders
Cryptocurrencies
Cybersecurity
Economic Calendar
Listed companies
Analyst Reco.
Rumors
IPOs
Capital Markets Transactions
New Contracts
Profit Warnings
Appointments
Press Releases
Events
Security Transactions
Financial Calendar
Sector News
Energy
Basic Materials
Industrials
Consumer Cyclical
Consumer Non-Cyclical
Financials
Healthcare
Technology
Real Estate
Utilities
ANALYSIS
All Analysis
Must Read
Weekly market update
Stock Trading Strategies
STOCK PICKS
All Stock Picks
Subscribe
PORTFOLIOS
My Portfolio
Virtual Portfolios
MarketScreener Portfolios
USA Portfolio
European Portfolio
Asian Portfolio
WATCHLISTS
My Watchlists
Watchlists
My previous session
My most visited
Most popular
Investment Style
Trend-Following Stocks
ESG stocks
Yield stocks
Momentum stocks
Growth stocks
Quality stocks
Investment Themes
The SPAC
Robotics
Strategic Metals
Ageing Population
Education
Sin stocks
RANKINGS
Top News
Most Read News
Hot News
Top Fundamentals
Top Capitalization
Top Yield
Top PER
Top Consensus
Top Fundamentals
Top ranking ESG
Top Technicals
Top RSI
Unusual volumes
Top Gaps
Top STIM
Breakouts
Trends
Top Movers
Top USA
Top Canada
Top U.K.
Top Germany
Top Europe
Top Asia
SCREENERS
Investment Themes
The Vegan Market
The future of mobility
Cybersecurity
Hydrogen
Europe's family businesses
Artificial Intelligence
Technical Rankings
Oversold stocks
Overbought stocks
Close to resistance
Close to support
Accumulation Phases
Most volatile stocks
Fundamental Rankings
Top Investor Rating
Top Trading Rating
Top Consensus
Growth stocks
Yield stocks
Low valuations
Stock Screener Home
My Screeners
All my stocks
Watchlists
Virtual Portfolios
TOOLS
MarketScreener tools
Stock Screener
iPhone App
Expert tools
Stock Screener PRO
Portfolio Creator
Event Screener
Tools
Dynamic Chart
Financial Calendar
Economic Calendar
Sector Research
Currency Converter
ProRealTime Trading
OUR SERVICES
Our subscriptions
MarketScreener Portfolios
European Portfolio
USA Portfolio
Asian Portfolio
Our Stock Picks
Thematic Investment Lists
Stock Screener
Homepage
Equities
Denmark
Nasdaq Copenhagen
Zealand Pharma A/S
News
Summary
ZEAL
DK0060257814
ZEALAND PHARMA A/S
(ZEAL)
Add to my list
Report
Delayed Nasdaq Copenhagen -
10:59 2022-08-15 am EDT
124.30
DKK
+5.34%
11:01a
European ADRs Move Sharply Lower in Monday Trading
MT
08/12
European ADRs Move Slightly Lower in Friday Trading
MT
08/11
European ADRs Move Lower in Thursday Trading
MT
Summary
Quotes
Charts
News
Ratings
Calendar
Company
Financials
Consensus
Revisions
Summary
Most relevant
All News
Analyst Reco.
Other languages
Press Releases
Official Publications
Sector news
European ADRs Move Lower in Wednesday Trading
05/18/2022 | 11:14am EDT
Send by mail :
Name :
First name :
From
*
:
To
*
:
(You can enter multiple email addresses separated by commas)
Message :
*
Required fields
© MT Newswires 2022
Stocks mentioned in the article
Change
Last
1st jan.
ADAPTIMMUNE THERAPEUTICS PLC
1.26%
2.41
-35.73%
AKARI THERAPEUTICS, PLC
1.00%
1.5
0.00%
AMARIN CORPORATION PLC
1.21%
1.67
-50.45%
AUTOLUS THERAPEUTICS PLC
5.32%
3.76
-27.55%
BICYCLE THERAPEUTICS PLC
0.57%
26.4
-56.63%
DBV TECHNOLOGIES
3.51%
5.165
68.85%
EDAP TMS S.A.
2.27%
7.66
27.88%
LOGITECH INTERNATIONAL S.A.
-0.58%
54.96
-28.10%
MEREO BIOPHARMA GROUP PLC
-3.70%
1.3
-18.75%
OPERA LIMITED
-2.94%
4.95
-29.89%
SAP SE
0.28%
93.29
-25.31%
SEQUANS COMMUNICATIONS S.A.
0.00%
3.4
-28.27%
TELEFÓNICA, S.A.
-0.91%
4.234
9.92%
TRINITY BIOTECH PLC
-2.13%
1.38
-3.50%
WPP PLC
1.58%
824.6
-26.34%
ZEALAND PHARMA A/S
5.34%
124.3
-18.68%
All news about ZEALAND PHARMA A/S
11:01a
European ADRs Move Sharply Lower in Monday Trading
MT
08/12
European ADRs Move Slightly Lower in Friday Trading
MT
08/11
European ADRs Move Lower in Thursday Trading
MT
08/11
TRANSCRIPT
: Zealand Pharma A/S, Q2 2022 Earnings Call, Aug 11, 2022
CI
08/11
Zealand Pharma H1 Net Operating Loss Narrows on Lower Revenue; Plans to Remove ADSs Fro..
MT
08/11
Zealand Pharma Announces Financial Results for the First Half of 2022
GL
08/11
Zealand Pharma Announces Financial Results for the First Half of 2022
AQ
08/11
Zealand Pharma A/S Revises Revenue Guidance for the Full Year of 2022
CI
08/11
Zealand Pharma A/S Reports Earnings Results for the Second Quarter and Six Months Ended..
CI
08/10
European ADRs Climb Higher in Wednesday Trading
MT
More news
Analyst Recommendations on ZEALAND PHARMA A/S
2021
ZEALAND PHARMA A/S
: Goldman Sachs Adjusts Price Target for Zealand Pharma A/S to $42 From..
MT
More recommendations
Financials
DKK
USD
Sales 2022
134 M
18,4 M
18,4 M
Net income 2022
-1 104 M
-151 M
-151 M
Net cash 2022
660 M
90,5 M
90,5 M
P/E ratio 2022
-3,52x
Yield 2022
-
Capitalization
5 751 M
788 M
788 M
EV / Sales 2022
38,0x
EV / Sales 2023
10,6x
Nbr of Employees
237
Free-Float
92,0%
More Financials
Chart ZEALAND PHARMA A/S
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Full-screen chart
Technical analysis trends ZEALAND PHARMA A/S
Short Term
Mid-Term
Long Term
Trends
Neutral
Bullish
Neutral
Technical analysis
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
More Financials
Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
124,30 DKK
Average target price
222,80 DKK
Spread / Average Target
79,2%
Consensus
EPS Revisions
Please enable JavaScript in your browser's settings to use dynamic charts.
More Estimates Revisions
Managers and Directors
Adam Sinding Steensberg
President & Chief Executive Officer
Matthew D. Dallas
Chief Financial Officer & Senior Vice President
Alf Gunnar Martin Nicklasson
Chairman
Ivan M. Møller
Executive VP-Technical Development & Operations
Danilo Verge
Head-Global Medical Affairs
More about the company
Sector and Competitors
1st jan.
Capi. (M$)
ZEALAND PHARMA A/S
-18.68%
753
GILEAD SCIENCES, INC.
-13.29%
78 912
VERTEX PHARMACEUTICALS
34.12%
75 532
REGENERON PHARMACEUTICALS, INC.
-0.45%
67 214
WUXI APPTEC CO., LTD.
-20.33%
40 830
BIONTECH SE
-37.80%
38 968
More Results
Master